We bring label-free interaction studies to the next level
Early lead identification aided by label-free technologies
Learn more about our SCORE technology and how it can enhance your search for pharmaceutically interesting compounds.
Our CEO Günther explains how this works and shows some selected examples. Read more in the recent publication of LABOonline (German article).Read all news
We have identified b-screen as an promising technology in the field of epitope mapping, and will now broaden our collaboration with Biametrics.
Dr. Markus Enzelberger, Senior VP, Head of Discovery Alliances & Technologies